[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350138-105":59,"doc-detail-350138-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-immunogenic-neoantigens-from-intron-retention-in-colorectal-cancer","Identification of immunogenic neoantigens from intron retention in colorectal cancer","","Intron retention (IR) provides an underexplored route to cancer neoantigens, especially in low tumor mutational burden settings such as microsatellite-stable colorectal cancer. Experimental results show IR-derived neoantigens are expressed in colorectal tumors and recognized by T cells, with ~30% of predicted epitopes inducing measurable CD8+ T cell responses. Using RNA-seq from 23 CRC patients, a pipeline identified 49 patient-specific and 24 shared IR-derived neoantigens, many with strong HLA binding, supporting vaccine potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-immunogenic-neoantigens-from-intron-retention-in-colorectal-cancer/350138/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-immunogenic-neoantigens-from-intron-retention-in-colorectal-cancer/350138.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are intron retention (IR)–derived neoantigens important in colorectal cancer?","Question",{"text":112,"@type":113},"IR-derived neoantigens can arise even when tumor mutational burden is low, including microsatellite-stable colorectal cancer. This makes them a potentially valuable source of tumor antigens beyond SNP-derived neoantigens.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were IR-derived neoantigens identified and validated in the study?",{"text":117,"@type":113},"The study integrated RNA sequencing data from 23 CRC patients and used a published bioinformatics pipeline to predict IR-derived neoantigens. Expression was confirmed by RT-PCR, and immunogenicity was evaluated using in vitro immune assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportion of predicted epitopes elicited CD8+ T cell responses?",{"text":121,"@type":113},"Approximately 30% of the predicted epitopes generated measurable CD8+ T cell responses, indicating that many IR-derived neoantigens are functionally immunogenic.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350138,1790183060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of immunogenic neoantigens from intron retention in colorectal cancer  \nThamizhanban Manoharan1,2,6, Brandon Bing Rui Kee2,6, Cyrus Zai Ming Cheng1,2, Malcolm Kaiheng Choy2, Bei En Siew3,4, Wai-Kit Cheong4, Kai-yin Lee4, Ian Jse-Wei Tan4, Bettina Lieske4, Choon Kong Yap5, Iain Bee HuatTan5, Ker-KanTan3,4, KarTong Tan2 & Gloryn Chia1,2􀀍  \nIntron retention (IR) is an underexplored source of alternative neoantigens in cancer. Unlike mutationderived neoantigens, IR-derived neoantigens can arise even in malignancies with low tumour mutational burden (TMB), such as microsatellite-stable colorectal cancer (MSS-CRC), making thema potentially important source of tumour antigens. Here, we provide experimental evidence that IRderived neoantigens are expressed in tumours and are recognized by T cells, with approximately 30% of predicted epitopes eliciting measurable CD8+ T cell responses. We applied a bioinformatics pipeline to RNA sequencing data from 23 CRC patients, identifying 49 patient-specific and 24 shared IR-derived neoantigens, the latter present in ~ 30% of the cohort. Notably, most shared neoantigens exhibited high binding affinity to the predominant HLA alleles, highlighting their potential as broadly targetable vaccine candidates. Together, these findings establish IR-derived neoantigens as a validated and clinically relevant class of tumour antigens, expanding opportunities for personalized and off-the-shelf immunotherapies inCRC and other low-TMB cancers.  \nKey words: Non canonical neoantigens, intron retention, cancer vaccines, colorectal cancer  \nNeoantigen cancer vaccines are highly personalized as neoantigens are predicted from patient’s tumour samples. These neoantigens are defined as tumour specific proteins that are absent in normal tissue but exist in tumour cells1. By vaccinating the patients against their neoantigens, cancer vaccines aim to prime the adaptive immune system to target the tumours and boost antitumour immunity2. Neoantigens used for cancer vaccines generation are usually predicted from single nucleotide polymorphisms (SNP) such as Single Nucleotide Variant (SNV) mutations, insertions and deletions (indels) . However, SNPs rarely give rise to immunogenic neoantigens and are highly patient-specific1. Moreover, low Tumour Mutational Burden (TMB) tumours, such as microsatellite stable colorectal cancer (MSS CRC), harbour few SNP-derived neoantigens, thereby limiting the effectiveness of SNP-based neoantigen vaccines3.  \nMultiple studies have demonstrated that neoantigens can arise from diverse sources, including alternative splicing, human endogenous retroviruses, and gene fusions4,5. By exploring these alternative sources, the repertoire of targetable antigens can be expanded, providing opportunities to develop more effective cancer vaccines for tumours with low mutational burden, such as MSS-CRC1. Importantly, many of these alternative neoantigens can be upregulated across patients and can be shared among different tumour types, offering abroader and more universal set of targets than patient-specific SNP-derived neoantigens6.  \nIntron retention (IR) is one such alternative source of neoantigens. IR occurs when intronic sequences are retained in mature mRNA after splicing, and in the cytoplasm these transcripts can escape nonsense-mediated decay (NMD) . When these retained intron transcripts are translated, they can give rise to alternative protein isoforms not normally produced in healthy cells, thereby serving as a potential source of neoantigens. Under normal conditions, introns are excised from exonic regions through cleavage at 5′ splice sites7. Spliceosome  \n1Institute for Health Innovation & Technology (iHealthtech), National University of Singapore, Singapore, Singapore. 2Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.  \n3Department of Surgery, Yong","cbCaiggAHRFy2Zi9","https://ap.wps.com/l/cbCaiggAHRFy2Zi9","pdf",2012956,12,"English","# Intron retention and neoantigens\n## Neoantigen cancer vaccines and limitations of SNP-derived targets\n## Alternative sources of neoantigens\n## IR mechanism and relevance to cancer\n## Study design: RNA-seq cohort, prediction pipeline, and validation","[{\"question\":\"Why are intron retention (IR)–derived neoantigens important in colorectal cancer?\",\"answer\":\"IR-derived neoantigens can arise even when tumor mutational burden is low, including microsatellite-stable colorectal cancer. This makes them a potentially valuable source of tumor antigens beyond SNP-derived neoantigens.\"},{\"question\":\"How were IR-derived neoantigens identified and validated in the study?\",\"answer\":\"The study integrated RNA sequencing data from 23 CRC patients and used a published bioinformatics pipeline to predict IR-derived neoantigens. Expression was confirmed by RT-PCR, and immunogenicity was evaluated using in vitro immune assays.\"},{\"question\":\"What proportion of predicted epitopes elicited CD8+ T cell responses?\",\"answer\":\"Approximately 30% of the predicted epitopes generated measurable CD8+ T cell responses, indicating that many IR-derived neoantigens are functionally immunogenic.\"}]","Identification of immunogenic neoantigens from intron retention in colorectal cancer | PDF",1790087333,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edc221d1acfbbbe69379da541a4f193b.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/125b07adb823a74d10aa43f52c5503d5.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32036db1795e596be01d923cfba33695.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8c264ceb8001712286ce89f86ef7fee.webp",980,1287]